Enriqueta Felip is the Head of the Thoracic and Head and Neck Cancer Unit within the Oncology Department of Vall d'Hebron Hospital, Barcelona, Spain. Professor Felip is in charge of thoracic malignancy management, and is responsible for thoracic cancer trials undertaken by the Oncology Department. Current research lines include the optimization of chemotherapy in early-stage disease, evaluation of new agents and therapies, research into novel pharmacogenomic approaches, the integration of immunotherapeutic approaches in the treatment of lung cancer patients, and the elucidation of potential mechanisms of resistance to tyrosine-kinase inhibitors.
Dr Felip received her medical degree from the UAB, where she also completed her PhD studies in medical oncology. She has been Associate Professor at the Autonomous University of Barcelona (UAB) from 2010 to May 2019. She is nowadays, Professor of Medicine at the Universitat de Vic (UVicc-UCC). She is involved in the training of medical students, residents and particularly in mentoring fellows.
Dr Felip is currently a member of the Spanish Lung Cancer Group (GECP) and the Spanish Society of Medical Oncology (SEOM). In October 2019, Dr. Felip was elected SEOM Vice-President for the following years 2019-2021. She is from October 2021 President of SEOM.
Dr. Felip is also member of the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), and the International Association for the Study of Lung Cancer (IASLC). Dr. Felip receives the 1st ESMO Women for Oncology Award in 2015.
Dr Felip has been involved in several initiatives with scientific organizations, among them, as Subject Editor of Guidelines Working group ESMO Minimum Clinical Recommendations in lung cancer and Coordinator of the 1st Lung Cancer ESMO Consensus Conference.
Dr Felip is also author of many peer-reviewed articles and book chapters relating to the field of thoracic malignancies.
EM-89207 - Date of preparation: February 2022